Teligent has confirmed previously mooted plans to consolidate significantly its outstanding shares, in order to maintain listing on the NASDAQ Capital Market.
The US topicals and injectables specialist has undergone a 1-for-10 reverse stock split, engineered towards increasing the per-share trading price...




